Evaluation of a Nutritional Technology for Vitamin D Absorption

Inclusion Criteria: * Adult participants (18-55 years of age) * Body mass index (BMI) \<30 kg/m2 * Males and nonpregnant, nonlactating females * Free of gastrointestinal disorders that my impact nutrient absorption in the small intestine, endocrine, hepatic, renal, or bone diseases Exclusion Criteria: * Use of vitamin D or calcium supplements within 3 weeks prior to the Screening Visit. * Use of a tanning booth/lamp within 3 weeks prior to the Screening Visit. * Travel to sunny location within 3 weeks prior to the Screening Visit. * Consumption of more than 3 alcoholic drinks per day starting 48 hours before the Screening Visit. * Has an allergy or intolerance to any ingredient in the study product. * Participating in another study that has not been approved as a concomitant study by Abbott Nutrition. * Use of the following medications that may have interactions with vitamin D absorption or metabolism: * Aluminum-containing phosphate binders * Anticonvulsants * Atorvastatin * Calcipotriene * Cholestyramine * Cytochrome P-450 3A4 substrates * Digoxin * Diltiazem * Orlistat * Thiazide diuretics * Corticosteroids * Stimulant laxatives * Verapamil